SVC Presentation UPDATE 2010 2 - Siripanna Chiang Mai, Chiang Mai, Thailand
Study design handout - Chiang Mai University
Transcript of Study design handout - Chiang Mai University
![Page 1: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/1.jpg)
Study Designs
Mathuramat Seesen, MDResearch Skill 2
![Page 2: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/2.jpg)
Study Design
•A framework, or the set of methods and procedures used to collect and analyze data on variables specified in a particular research problem
![Page 3: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/3.jpg)
Research DesignsQaulitative Quantitative
Focus Quality Quantity
Goals Understanding, hypothesis generating
Prediction, hypothesis testing
Data collection Interview, Observation Survey, constructed questionnaire, experiment
Data Text, stories Numbers
Sample size Small Large
![Page 4: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/4.jpg)
Research Designs
Qualitative Quantitative
Observational Experimental
Descriptive Analytic
![Page 5: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/5.jpg)
Observational Study•Documenting a naturally occurring relationship
between the exposure and the outcome
•The researcher does not do any active intervention.
•e.g. evaluate the incidence of diabetes in Thailand, compare the treatment result between patients who have high and low educational levels
•Divided into Descriptive and Analytical study
![Page 6: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/6.jpg)
Experimental Study
•Intervention study
•Conditions are under the direct control of the researcher.
![Page 7: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/7.jpg)
Research Designs
Qualitative Quantitative
Observational Experimental
Descriptive Analytic
![Page 8: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/8.jpg)
Observational Study
AnalyticDescriptive
Incidence Study
Prevalence Study
Cross-sectional Study
Case-control Study
Cohort Study
![Page 9: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/9.jpg)
Prevalence
• Proportion of individuals who have a specific characteristic in a given time period
Prevalence = Number of cases
Number of population
![Page 10: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/10.jpg)
Observational Study
AnalyticDescriptive
Incidence Study
Prevalence Study
Cross-sectional Study
Case-control Study
Cohort Study
![Page 11: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/11.jpg)
Cross-sectional study• The outcome and the exposures in participants were measured at
the same time
• Estimate Prevalence
• Calculate Odds Ratio
• Prevalence in exposed > un-exposed —> the exposure may be a cause of disease
• Pros: quick, cheap, yields prevalence
• Cons: difficult to derive causal relationships
![Page 12: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/12.jpg)
Cross-sectional study
Risk factor;
Disease
Risk factor;
No disease No risk factor;
Disease
No risk factor;
No diseasePopulation
Sample
The present
![Page 13: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/13.jpg)
Prevalence Ratio
PR = Prevalence of disease in exposed
Prevalence of disease in Unexposed
![Page 14: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/14.jpg)
Disease No disease
Exposed a b a+b
Unexposed c d c+d
a+c b+d a+b+c+d
PR = Prevalence of disease in exposed
Prevalence of disease in non-exposed= a / (a+b)
c / (c+d)
![Page 15: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/15.jpg)
Cirrhosis No cirrhosis
80 20 100
10 50 60
90 70 160
![Page 16: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/16.jpg)
Prevalence Ratio
PR = ?
Interpretation ?
Cirrhosis No cirrhosis
Alcohol 80 20 100No
alcohol 10 50 60
90 70 160
![Page 17: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/17.jpg)
Incidence
• The occurrence of new cases of disease or injury in a population over a specified period of time
Cumulative incidence = Number of new cases within a specific time period
Population at risk
![Page 18: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/18.jpg)
Observational Study
AnalyticDescriptive
Incidence Study
Prevalence Study
Cross-sectional Study
Case-control Study
Cohort Study
![Page 19: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/19.jpg)
Cohort Study
Prospective Retrospective
![Page 20: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/20.jpg)
Prospective Cohort Study• Longitudinal study, Follow-up study
• Follow disease-free study population over a period of time
• Incidence in exposed > unexposed —> the exposure may be a cause of disease
• Pros: explain causal relationship, yields incidence
• Cons: expensive, take long time, need large sample size
![Page 21: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/21.jpg)
Prospective Cohort Study
Risk factor present
Risk factor absentPopulation
Sample
The present
Disease No disease
Disease No disease
The future
![Page 22: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/22.jpg)
Retrospective Cohort Study• Historical cohort
• Researcher starts the study at the time follow-up has already been completed
• Pros: quick
• Cons: work with what has been measured in the past, often for another purpose
![Page 23: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/23.jpg)
Retrospective Cohort Study
Risk factor present
Risk factor absentPopulation
Sample
The past
Disease No disease
Disease No disease
The present
![Page 24: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/24.jpg)
Risk Ratio• Relative risk
• Risk = number of new cases divided by the total population-at-risk
RR = Risk of disease in exposed
Risk of disease in unexposed
![Page 25: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/25.jpg)
Disease No disease
Exposed a b a+b
Unexposed c d c+d
a+c b+d a+b+c+d
RR = Risk of disease in exposed
Risk of disease in unexposed= a / (a+b)
c / (c+d)
![Page 26: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/26.jpg)
Observational Study
AnalyticDescriptive
Incidence Study
Prevalence Study
Cross-sectional Study
Case-control Study
Cohort Study
![Page 27: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/27.jpg)
Case-control Study• Identify the cases and controls (a group known to be free of the
disease)
• Study the exposure in both groups
• If case has exposed > control —> the potential risk factor may be a cause of the disease
• Always retrospective
• Pros: efficient for rare diseases/ diseases with the long latency period
• Cons: prone to bias, no prevalence and incidence
![Page 28: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/28.jpg)
Case-control Study
PopulationSample of cases
The past
Disease
No disease
The present
Risk factor absent
Risk factor absent
with disease
Sample of controlsPopulation
withoutdisease
Risk factor
present
Risk factor present
![Page 29: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/29.jpg)
Probability
•Probabilities: proportion of chance of having interesting events out of all possibilities
•Throwing a dice: probability of getting “1”= 1/6
![Page 30: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/30.jpg)
Odds•Ratio of chance of having interesting events over
chance of having non-interesting events
•Throwing a dice: Odds of getting “1”= ?
Odds = Probability Probability = Odds
1- Probability 1+ Odds
![Page 31: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/31.jpg)
Odds Ratio• No prevalence or incidence in case-control study
• Not possible to calculate RR
OR = Odds of exposed in case
Odds of exposed in control
![Page 32: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/32.jpg)
Case Control
Exposed a b a+b
Unexposed c d c+d
a+c b+d a+b+c+d
OR = Odds of exposed in case
Odds of exposed in control= a / c
b / d
= a*d
b*c
![Page 33: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/33.jpg)
Exposure OR = Disease OR• In Case-control study, we
calculate exposure OR
Exposure OR = ?
• In Cohort study, we calculate disease OR
Disease OR = ?
Cirrhosis No cirrhosis
Alcohol 80 20 100No
alcohol 10 50 60
90 70 160
![Page 34: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/34.jpg)
OR ~ RR• In other study design e.g.
cross-sectional, cohort
• When disease is rare, OR is similar to RR
OR = ?
RR = ?
Rare disease
No disease
Expose 80 20 100Un
exposed 10 50 60
90 70 160
![Page 35: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/35.jpg)
OR and RR interpretation• No unit
• 0 - infinity
0 = No association
>1 = Positive association
(Exposure is a risk factor)
<1 = Inverse association
(Exposure is a protective factor)
![Page 36: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/36.jpg)
Experimental Study
![Page 37: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/37.jpg)
Phases of Clinical Trial
In vitro/ animal
Healthy volunteers
(10-100)
Patients
(100-1,000)
Patients
(1,000-10,000
Post-marketing
surveillance
1 2 3 4
PharmacokineticPharmacodynamic
Side effectsSafety Further safety study
Efficacy Confirm efficacy
Available in public
RCT
![Page 38: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/38.jpg)
Randomized Controlled Trial (RCT)
• Provide strong evidence of a cause-effect relation
• Participants are randomly assigned to an experimental and a control group.
• Control group receives another treatment or a placebo.
• Blinding
• Double blind: participants and investigators
![Page 39: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/39.jpg)
Randomized Controlled Trial (RCT)
Intervention
Population
Sample
The present
Bad outcome
Good outcome
The future
Control
Randomize
Bad outcome
Good outcome
![Page 40: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/40.jpg)
Other Designs
![Page 41: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/41.jpg)
Crossover study• Participants serve as their own control
• Randomly assign participants —> switch treatment
• Washout period
• Pros: reduce influence by confounders,
• Cons: carryover effects, period effects (resistance/disease progression)
![Page 42: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/42.jpg)
![Page 43: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/43.jpg)
Systematic Review
• Collects all possible studies related to a given topic and design
• Reviews and analyzes their results
![Page 44: Study design handout - Chiang Mai University](https://reader033.fdocuments.net/reader033/viewer/2022042114/62579ffa60256e250a16f309/html5/thumbnails/44.jpg)
Meta-analysis
• Statistical process of analyzing and combining results from several similar studies
• Publication bias